title: Effects of ranolazine on quality of life among patients with diabetes mellitus and stable angina.
authors.affiliation: St Luke's Mid America Heart Institute, Kansas City, Missouri2University of Missouri-Kansas City.
authors.forename: Suzanne V
authors.initials: SV
authors.lastname: Arnold
authors.affiliation: St Luke's Mid America Heart Institute, Kansas City, Missouri2University of Missouri-Kansas City.
authors.forename: Mikhail
authors.initials: M
authors.lastname: Kosiborod
authors.affiliation: University of Texas Southwestern Medical Center, Dallas.
authors.forename: Darren K
authors.initials: DK
authors.lastname: McGuire
authors.affiliation: St Luke's Mid America Heart Institute, Kansas City, Missouri.
authors.forename: Yan
authors.initials: Y
authors.lastname: Li
authors.affiliation: Gilead Sciences, Foster City, California.
authors.forename: Patrick
authors.initials: P
authors.lastname: Yue
authors.affiliation: Cardiovascular Research Foundation, New York, New York.
authors.forename: Ori
authors.initials: O
authors.lastname: Ben-Yehuda
authors.affiliation: St Luke's Mid America Heart Institute, Kansas City, Missouri2University of Missouri-Kansas City.
authors.forename: John A
authors.initials: JA
authors.lastname: Spertus
mesh_terms: D000083:Acetanilides / Q000627:therapeutic use*; D000368:Aged; D060050:Angina, Stable / Q000150:complications / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004311:Double-Blind Method; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000627:therapeutic use; D017060:Patient Satisfaction; D010879:Piperazines / Q000627:therapeutic use*; D011788:Quality of Life; D000069458:Ranolazine; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use
chemical_list: D000083:Acetanilides; D004791:Enzyme Inhibitors; D010879:Piperazines; D014665:Vasodilator Agents; D000069458:Ranolazine; D005996:Nitroglycerin